Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRUSMI: Ultrasound and Microbubbles in Acute STEMI
NCT02170103Completed
- Sponsor
- University of Nebraska
- Start
- Sep 2018
- Primary completion
- Mar 2023
- Modality
- Drug Delivery Systems
- Countries
- 2
01
Overview
Randomised, open-label trial of perflutren in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by University of Nebraska. Primary endpoints: Six month event free survival at 6 months, Myocardial salvageability index and 1 more. Started Sep 2018; status: completed.
02
Drugs
perflutren
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02170103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170103.